Step Forward. Join The Fight Against Diabetic Nerve Pain.

Nearly 40 million people in the United States have Diabetes. Up 50% of those who live with the disease will develop Diabetic Nerve Pain (caused by Diabetic Polyneuropathy, or DPN), a complication related to high blood sugar and triglycerides in the blood. The longer an individual has Diabetes, the higher the risk for nerve pain.

The condition affects the lower extremities (the hip, knee, and ankle joints, and the bones of the thigh, leg, and foot). Standing and walking may become intolerable. Sleep doesn’t offer much relief because it’s hard to come by: the pain may be worse at night. As with other types of chronic pain, depression and anxiety are common.

No specific medications have been designed to target Diabetic Nerve Pain. First-line prescription drugs include antidepressants and anticonvulsants, which weren’t designed to treat pain and may be ineffective or cause unwanted side effects.

Take the next step to see if you qualify for local research studies for people with nerve pain due to type 1 or type 2 diabetes. But don’t delay — space is limited!

Get started now

How does it work?


Tell us a little bit about yourself


Answer some questions about your health


We will connect you to available studies in your area

Just takes a few minutes

Get started now

COVID-19 update — we remain open.

For the safety of both staff and patients, we require that our research sites are COVID-19 SMART facilities. That means they use best practices to reduce virus exposure and are dedicated to ensuring they remain open and available for the research of investigational medications.

COVID-19 SMART steps we are taking to ensure safety include:

  • Greatly increased availability of video office visits
  • Ensuring social distancing measures are taken in all waiting areas
  • Continuing the practice of cleaning and disinfecting exam rooms thoroughly between every visit
  • Appropriate personal protective equipment (PPE) for all staff members at our health clinics

AcurianHealth helps connect people with research studies that offer treatment under development. Since 1998, AcurianHealth has referred 1 million study candidates to 800 studies in 70 countries.